T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alcon
ALC
|
+$2.23B |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$1.45B |
| 3 |
Linde
LIN
|
+$1.44B |
| 4 |
American International
AIG
|
+$1.43B |
| 5 |
Marvell Technology
MRVL
|
+$1.31B |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$2.31B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.58B |
| 4 |
Eli Lilly
LLY
|
+$1.54B |
| 5 |
Booking.com
BKNG
|
+$1.17B |
Sector Composition
| 1 | Technology | 18.89% |
| 2 | Healthcare | 16.97% |
| 3 | Financials | 13.8% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
First Bancorp
FBNC
$2.29B
| $38.3M | 0.01% |
1,051,108
-6,779
| -0.6% | -$247K |
|
|
ODT
977
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $38.2M | 0.01% |
1,042,446
+672,721
| +182% | +$24.7M |
|
978
Medpace
MEDP
$13.8B
| $37.9M | 0.01% |
578,979
+283,143
| +96% | +$18.5M |
|
979
PDF Solutions
PDFS
$773M
| $37.5M | 0.01% |
2,861,709
-97,894
| -3% | -$1.28M |
|
980
Nexstar Media Group
NXST
$6.27B
| $37.4M | 0.01% |
369,856
+133,739
| +57% | +$13.5M |
|
981
Krystal Biotech
KRYS
$4.12B
| $37.3M | 0.01% |
927,079
+622,959
| +205% | +$25.1M |
|
982
Stoneridge
SRI
$229M
| $37.3M | 0.01% |
1,181,223
+1,166,672
| +8,018% | +$36.8M |
|
|
ELME
983
Elme Communities
ELME
$1.5B
| $36.8M | 0.01% |
1,377,484
-986,742
| -42% | -$26.4M |
|
984
Ameris Bancorp
ABCB
$5.11B
| $36.8M | 0.01% |
939,198
-181
| -0% | -$7.09K |
|
|
CBIO
985
Crescent Biopharma, Inc. Common Stock
CBIO
$175M
| $36.3M | 0.01% |
30,444
-3,798
| -11% | -$4.53M |
|
|
TPTX
986
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $36.2M | 0.01% |
+890,050
| New | +$36.2M |
|
|
ECOL
987
DELISTED
US Ecology, Inc.
ECOL
| $36.2M | 0.01% |
607,911
-15,168
| -2% | -$903K |
|
988
Brown-Forman Class B
BF.B
$12.8B
| $36.2M | 0.01% |
652,910
+2,220
| +0.3% | +$123K |
|
989
Hilton Grand Vacations
HGV
$4.01B
| $36.1M | 0.01% |
1,133,442
+3,583
| +0.3% | +$114K |
|
990
NetEase
NTES
$96.4B
| $35.8M | 0.01% |
699,560
-282,630
| -29% | -$14.5M |
|
991
Equity Bancshares
EQBK
$799M
| $35.7M | 0.01% |
1,337,262
+72,385
| +6% | +$1.93M |
|
992
Luxfer Holdings
LXFR
$359M
| $35.5M | 0.01% |
1,446,689
-1,017,739
| -41% | -$25M |
|
|
XYZ
993
Block, Inc.
XYZ
$44.8B
| $35.3M | 0.01% |
486,962
-132,653
| -21% | -$9.62M |
|
994
Milestone Pharmaceuticals
MIST
$165M
| $35.3M | 0.01% |
+1,299,946
| New | +$35.3M |
|
995
Healthpeak Properties
DOC
$12.6B
| $35.3M | 0.01% |
1,102,557
+253,314
| +30% | +$8.1M |
|
996
CyberArk
CYBR
$23.6B
| $35.2M | ﹤0.01% |
275,525
-455,610
| -62% | -$58.2M |
|
997
ScottsMiracle-Gro
SMG
$3.5B
| $35M | ﹤0.01% |
355,565
-3,275
| -0.9% | -$323K |
|
998
Quanterix
QTRX
$223M
| $34.8M | ﹤0.01% |
1,030,830
+37,869
| +4% | +$1.28M |
|
999
CRISPR Therapeutics
CRSP
$5.08B
| $34.8M | ﹤0.01% |
738,869
+121,176
| +20% | +$5.71M |
|
1000
Addus HomeCare
ADUS
$2.03B
| $34.6M | ﹤0.01% |
461,971
-305
| -0.1% | -$22.9K |
|